A detailed history of Voloridge Investment Management, LLC transactions in Iovance Biotherapeutics, Inc. stock. As of the latest transaction made, Voloridge Investment Management, LLC holds 109,953 shares of IOVA stock, worth $895,017. This represents 0.0% of its overall portfolio holdings.

Number of Shares
109,953
Previous 2,491,659 95.59%
Holding current value
$895,017
Previous $20 Million 94.84%
% of portfolio
0.0%
Previous 0.08%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$7.28 - $11.9 $17.3 Million - $28.3 Million
-2,381,706 Reduced 95.59%
109,953 $1.03 Million
Q2 2024

Aug 14, 2024

SELL
$7.78 - $14.19 $7.8 Million - $14.2 Million
-1,002,525 Reduced 28.69%
2,491,659 $20 Million
Q1 2024

May 15, 2024

BUY
$7.59 - $17.47 $19.1 Million - $43.9 Million
2,511,104 Added 255.43%
3,494,184 $51.8 Million
Q4 2023

Feb 14, 2024

BUY
$3.3 - $8.89 $2.58 Million - $6.96 Million
782,656 Added 390.5%
983,080 $7.99 Million
Q3 2023

Nov 14, 2023

SELL
$4.44 - $8.79 $1.46 Million - $2.9 Million
-329,718 Reduced 62.19%
200,424 $911,000
Q2 2023

Aug 14, 2023

SELL
$5.36 - $9.06 $3.21 Million - $5.42 Million
-598,771 Reduced 53.04%
530,142 $3.73 Million
Q1 2023

May 15, 2023

SELL
$5.53 - $8.22 $3.22 Million - $4.78 Million
-581,929 Reduced 34.01%
1,128,913 $6.9 Million
Q4 2022

Feb 14, 2023

BUY
$5.62 - $10.0 $1.51 Million - $2.68 Million
267,794 Added 18.56%
1,710,842 $10.9 Million
Q3 2022

Nov 14, 2022

BUY
$9.53 - $13.11 $4.17 Million - $5.74 Million
437,941 Added 43.57%
1,443,048 $13.8 Million
Q2 2022

Aug 15, 2022

BUY
$6.38 - $18.33 $1.66 Million - $4.76 Million
259,895 Added 34.88%
1,005,107 $11.1 Million
Q1 2022

May 16, 2022

BUY
$12.38 - $19.1 $1.75 Million - $2.7 Million
141,536 Added 23.45%
745,212 $12.4 Million
Q4 2021

Feb 14, 2022

SELL
$16.55 - $27.63 $575,244 - $960,363
-34,758 Reduced 5.44%
603,676 $11.5 Million
Q3 2021

Nov 15, 2021

SELL
$20.35 - $26.63 $1.12 Million - $1.47 Million
-55,183 Reduced 7.96%
638,434 $15.7 Million
Q2 2021

Aug 16, 2021

BUY
$16.33 - $33.07 $9.95 Million - $20.2 Million
609,506 Added 724.64%
693,617 $18 Million
Q1 2021

May 17, 2021

BUY
$28.67 - $52.59 $1.37 Million - $2.51 Million
47,800 Added 131.64%
84,111 $2.66 Million
Q4 2020

Feb 16, 2021

BUY
$28.04 - $50.26 $1.02 Million - $1.82 Million
36,311 New
36,311 $1.69 Million

Others Institutions Holding IOVA

About IOVANCE BIOTHERAPEUTICS, INC.


  • Ticker IOVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 157,800,992
  • Market Cap $1.28B
  • Description
  • Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...
More about IOVA
Track This Portfolio

Track Voloridge Investment Management, LLC Portfolio

Follow Voloridge Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Voloridge Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voloridge Investment Management, LLC with notifications on news.